Market Overview:
The global lab screening test kit market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of infectious diseases, rising demand for blood glucose monitoring, and growing awareness about clinical testing. Based on type, the global lab screening test kit market is segmented into clinical testing, infectious disease testing, blood glucose monitoring, and other segments. Clinical testing is further sub-segmented into pathology tests, drug tests, genetic tests and other types of clinical tests. Infectious disease testing is further sub-segmented into viral diseasestesting , bacterial diseasestesting , parasitic diseasestesting and fungal diseasestesting . Blood glucose monitoringis further sub-segmentedinto home blood glucose monitorsand professionalglucose meters . Based on application, the global lab screening test kit market is segmented into hospital laboratories,, clinic laboratories,, diagnostic laboratories,, Point-of-Care Testing (POCT) Laboratoriesand other applications segments.
Product Definition:
A lab screening test kit is a device used to test a sample for the presence of one or more particular substances. The importance of lab screening tests kits varies depending on the application, but they can be critical in ensuring that samples are properly analyzed and that results are accurate.
Clinical Testing:
Clinical testing is a procedure carried out to evaluate the efficacy of new drug molecules in humans after they are screened for their therapeutic efficacy in animals. The process involves clinical trials, also called as “testing” or “clinical research”.
Global Clinical Testing Market by Type (In Vitro, In Vivo), by Region (North America, Europe, Asia Pacific Excluding Japan).
Infectious Disease Testing:
Infectious disease testing is the branch of clinical laboratory science that deals with detection, prevention, and treatment of diseases caused by microorganisms such as bacteria, viruses or fungi. Infectious diseases are mainly responsible for morbidity (inability to carry on with daily activities due to illness) and mortality (death) in humans globally. The introduction of advanced diagnostic technologies has led to early diagnosis and increased survival rates in patients suffering from various infectious diseases.
Application Insights:
The hospital application segment led the global lab screening test kit market in 2017. The hospital-based settings are generally equipped with advanced diagnostic equipment for easy and rapid testing of samples. This helps in early diagnosis, which is a key factor for generating higher revenue. In addition, the rising prevalence of chronic diseases such as cancer and cardiovascular diseases is expected to drive demand for point-of-care tests at hospitals and clinics over the forecast period.
The other application segment includes home healthcare settings that use portable devices or those that can be installed at home without requiring any professional help or installation process. These types of kits are used by people who travel frequently to remote areas where there is no access to a laboratory or where blood sample cannot be taken easily such as military personnel, disaster response team members etcetera.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biotechnology and pharmaceutical companies, which are involved in drug discovery & development processes. These companies are focusing on pre-clinical and clinical testing for new drug molecules as well as vaccines, thus driving the demand for lab screening tests. Moreover, increasing government funding towards infectious disease research is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income levels coupled with growing healthcare awareness among people; these factors have led to an increase in demand for laboratory services over this region.
Growth Factors:
- Increasing incidence of lifestyle diseases and growing awareness about early diagnosis and treatment: The increasing incidence of lifestyle diseases, such as diabetes, heart disease, and cancer is driving the demand for lab screening test kits. Growing awareness about the benefits of early diagnosis and treatment is also contributing to the growth of this market.
- Technological advancements in lab screening test kits: The development of novel technologies has led to the introduction of advanced lab screening test kits that are more accurate and efficient than traditional methods. This is helping to boost the demand for these products worldwide.
- Rising healthcare expenditure: The rising healthcare expenditure by governments and private players is fueling the growth of the global lab screening test kit market as it enables patients to have access to better diagnostic facilities.
Scope Of The Report
Report Attributes
Report Details
Report Title
Lab Screening Test Kit Market Research Report
By Type
Clinical Testing, Infectious Disease Testing, Blood Glucose Monitoring, Other
By Application
Hospital, Clinic, Diagnostic Laboratory, Other
By Companies
Mylab Discovery Solutions, Abott, Hologic, Thermo-Fisher Scientific, LabCorp, Roche Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Lab Screening Test Kit Market Report Segments:
The global Lab Screening Test Kit market is segmented on the basis of:
Types
Clinical Testing, Infectious Disease Testing, Blood Glucose Monitoring, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Diagnostic Laboratory, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylab Discovery Solutions
- Abott
- Hologic
- Thermo-Fisher Scientific
- LabCorp
- Roche Diagnostics
Highlights of The Lab Screening Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Clinical Testing
- Infectious Disease Testing
- Blood Glucose Monitoring
- Other
- By Application:
- Hospital
- Clinic
- Diagnostic Laboratory
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lab Screening Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lab screening test kit is a collection of different laboratory tests that can be used to screen for various diseases.
Some of the key players operating in the lab screening test kit market are Mylab Discovery Solutions, Abott, Hologic, Thermo-Fisher Scientific, LabCorp, Roche Diagnostics.
The lab screening test kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lab Screening Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lab Screening Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lab Screening Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lab Screening Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lab Screening Test Kit Market Size & Forecast, 2018-2028
4.5.1 Lab Screening Test Kit Market Size and Y-o-Y Growth
4.5.2 Lab Screening Test Kit Market Absolute $ Opportunity
Chapter 5 Global Lab Screening Test Kit Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Lab Screening Test Kit Market Size Forecast by Type
5.2.1 Clinical Testing
5.2.2 Infectious Disease Testing
5.2.3 Blood Glucose Monitoring
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Lab Screening Test Kit Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Lab Screening Test Kit Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Diagnostic Laboratory
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lab Screening Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lab Screening Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Lab Screening Test Kit Analysis and Forecast
9.1 Introduction
9.2 North America Lab Screening Test Kit Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Lab Screening Test Kit Market Size Forecast by Type
9.6.1 Clinical Testing
9.6.2 Infectious Disease Testing
9.6.3 Blood Glucose Monitoring
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Lab Screening Test Kit Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Diagnostic Laboratory
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Lab Screening Test Kit Analysis and Forecast
10.1 Introduction
10.2 Europe Lab Screening Test Kit Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Lab Screening Test Kit Market Size Forecast by Type
10.6.1 Clinical Testing
10.6.2 Infectious Disease Testing
10.6.3 Blood Glucose Monitoring
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Lab Screening Test Kit Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Diagnostic Laboratory
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Lab Screening Test Kit Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Lab Screening Test Kit Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Lab Screening Test Kit Market Size Forecast by Type
11.6.1 Clinical Testing
11.6.2 Infectious Disease Testing
11.6.3 Blood Glucose Monitoring
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Lab Screening Test Kit Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Diagnostic Laboratory
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Lab Screening Test Kit Analysis and Forecast
12.1 Introduction
12.2 Latin America Lab Screening Test Kit Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Lab Screening Test Kit Market Size Forecast by Type
12.6.1 Clinical Testing
12.6.2 Infectious Disease Testing
12.6.3 Blood Glucose Monitoring
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Lab Screening Test Kit Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Diagnostic Laboratory
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Lab Screening Test Kit Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Lab Screening Test Kit Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Lab Screening Test Kit Market Size Forecast by Type
13.6.1 Clinical Testing
13.6.2 Infectious Disease Testing
13.6.3 Blood Glucose Monitoring
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Lab Screening Test Kit Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Diagnostic Laboratory
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lab Screening Test Kit Market: Competitive Dashboard
14.2 Global Lab Screening Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylab Discovery Solutions
14.3.2 Abott
14.3.3 Hologic
14.3.4 Thermo-Fisher Scientific
14.3.5 LabCorp
14.3.6 Roche Diagnostics
